Sera tested for possible non-specific crossreactivity and positive results
| Sera demonstrating antibodies to | No. tested | In house ELISAs and MAT | PanBio | Biolisa with sorbent | Biolisa without sorbent | IHA |
|---|---|---|---|---|---|---|
| *A further 10/142 (7.0%) gave borderline results. | ||||||
| **A further 9/142 (6.3%) gave borderline results. | ||||||
| CMV, cytomegalovirus; EBV, Epstein-Barr virus; ELISA, enzyme linked immunosorbent assay; HAV, hepatitis A virus; IHA, indirect haemagglutination assay; MAT, microscopic agglutination test. | ||||||
| Toxoplasma | 25 | 0 | 0 | 1 | 3 | 0 |
| EBV | 19 | 0 | 0 | 2 | 5 | 0 |
| HAV | 21 | 0 | 0 | 6 | 8 | 0 |
| Rheumatoid factor | 14 | 0 | 0 | 1 | 2 | 0 |
| Borrelia burgdorferi | 15 | 0 | 0 | 0 | 2 | 0 |
| Mycoplasma | 13 | 0 | 0 | 0 | 3 | 1 |
| Syphilis | 13 | 0 | 0 | 1 | 2 | 0 |
| CMV | 14 | 0 | 1 | 0 | 0 | 0 |
| Q fever | 8 | 0 | 0 | 0 | 0 | 0 |
| Total | 142 | |||||
| Positivity (% of total tested) | 0/142 (0%) | 1/142 (0.7%) | 11/142* (7.7%) | 25/142** (17.6%) | 1/142 (0.7%) | |